These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 27540256)

  • 1. PAEDIATRIC ADVERSE DRUG REACTIONS (ADRS): A COMPARISON OF A NEWLY DEVELOPED AVOIDABILITY TOOL TO EXISTING HALLAS ASSESSMENTS.
    Bracken L; Kirkham J; Nunn A; Pirmohamed M; Peak M; Turner M
    Arch Dis Child; 2016 Sep; 101(9):e2. PubMed ID: 27540256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of the Liverpool Adverse Drug Reaction Avoidability Assessment Tool.
    Bracken LE; Nunn AJ; Kirkham JJ; Peak M; Arnott J; Smyth RL; Pirmohamed M; Turner MA
    PLoS One; 2017; 12(1):e0169393. PubMed ID: 28046035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a geriatric unit: a prospective study of 1756 patients.
    Franceschi M; Scarcelli C; Niro V; Seripa D; Pazienza AM; Pepe G; Colusso AM; Pacilli L; Pilotto A
    Drug Saf; 2008; 31(6):545-56. PubMed ID: 18484788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An investigation into the avoidability of adverse drug reactions using the LAAT and modified Hallas tools.
    Danjuma MI; Shokri SA; Abubeker IY; Malik AE; Abdallah IMH; Shafei MNE; Fatima H; Mahmoud M; Hussain T; Maghoub Y; Sajid J; Zouki ANE
    Medicine (Baltimore); 2020 Jan; 99(1):e18569. PubMed ID: 31895800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Avoidability of drug-induced liver injury (DILI) in an elderly hospital cohort with cases assessed for causality by the updated RUCAM score.
    Danjuma MI; Almasri H; Alshokri S; Khir FK; Elmalik A; Battikh NG; Abdallah IMH; Elshafei M; Fatima H; Mohamed MFH; Maghoub Y; Hussain T; Kamal I; Anwer Z; Bidmos MA; Elzouki AN
    BMC Geriatr; 2020 Sep; 20(1):346. PubMed ID: 32928134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determining the frequency and preventability of adverse drug reaction-related admissions to an Irish University Hospital: a cross-sectional study.
    Ahern F; Sahm LJ; Lynch D; McCarthy S
    Emerg Med J; 2014 Jan; 31(1):24-9. PubMed ID: 23389832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective, observational study of adverse reactions to drug regimen for multi-drug resistant pulmonary tuberculosis in central India.
    Hire R; Kale AS; Dakhale GN; Gaikwad N
    Mediterr J Hematol Infect Dis; 2014; 6(1):e2014061. PubMed ID: 25237474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse drug reactions in an ageing PopulaTion (ADAPT) study: Prevalence and risk factors associated with adverse drug reaction-related hospital admissions in older patients.
    Cahir C; Curran C; Walsh C; Hickey A; Brannigan R; Kirke C; Williams DJ; Bennett K
    Front Pharmacol; 2022; 13():1029067. PubMed ID: 36712658
    [No Abstract]   [Full Text] [Related]  

  • 9. Adverse Drug Reactions in an Oncological Population: Prevalence, Predictability, and Preventability.
    Lavan AH; O'Mahony D; Buckley M; O'Mahony D; Gallagher P
    Oncologist; 2019 Sep; 24(9):e968-e977. PubMed ID: 30833488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translation, transcultural adaptation and validation to Brazilian Portuguese of tools for adverse drug reaction assessment in children.
    da Costa Lima E; de Barros Fernandes T; Freitas A; de Lima Sias JF; Land MGP; Aires MT; Bracken L; Peak M
    BMC Med Res Methodol; 2021 Jul; 21(1):141. PubMed ID: 34238235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hospital re-admission associated with adverse drug reactions in patients over the age of 65 years.
    Hauviller L; Eyvrard F; Garnault V; Rousseau V; Molinier L; Montastruc JL; Bagheri H
    Eur J Clin Pharmacol; 2016 May; 72(5):631-9. PubMed ID: 26884320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes.
    Davies EC; Green CF; Taylor S; Williamson PR; Mottram DR; Pirmohamed M
    PLoS One; 2009; 4(2):e4439. PubMed ID: 19209224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Avoidability of adverse drug reactions spontaneously reported to a French regional drug monitoring centre.
    Jonville-Béra AP; Saissi H; Bensouda-Grimaldi L; Beau-Salinas F; Cissoko H; Giraudeau B; Autret-Leca E
    Drug Saf; 2009; 32(5):429-40. PubMed ID: 19419237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse drug reaction-related hospitalisations: a population-based cohort study.
    van der Hooft CS; Dieleman JP; Siemes C; Aarnoudse AJ; Verhamme KM; Stricker BH; Sturkenboom MC
    Pharmacoepidemiol Drug Saf; 2008 Apr; 17(4):365-71. PubMed ID: 18302300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early rehospitalizations of frail elderly patients - the role of medications: a clinical, prospective, observational trial.
    Ekerstad N; Bylin K; Karlson BW
    Drug Healthc Patient Saf; 2017; 9():77-88. PubMed ID: 28860862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of Antibiotics in Hospitalized Children in Romania: A Prospective Observational Study.
    Bulik NB; Farcaș A; Bucșa C; Iaru I; Oniga O
    Pharmaceuticals (Basel); 2022 Jun; 15(6):. PubMed ID: 35745632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse drug reactions in hospital in-patients: a pilot study.
    Davies EC; Green CF; Mottram DR; Pirmohamed M
    J Clin Pharm Ther; 2006 Aug; 31(4):335-41. PubMed ID: 16882102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug interactions and adverse drug reactions in the older patients admitted to the emergency department.
    De Paepe P; Petrovic M; Outtier L; Van Maele G; Buylaert W
    Acta Clin Belg; 2013; 68(1):15-21. PubMed ID: 23627189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective analysis of the preventability of adverse drug reactions reported in Sweden.
    Lövborg H; Eriksson LR; Jönsson AK; Bradley T; Hägg S
    Eur J Clin Pharmacol; 2012 Aug; 68(8):1183-9. PubMed ID: 22349466
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.